Satellos Bioscience, Inc. (MSLE)
6.86
+0.51
(+8.03%)
USD |
NASDAQ |
Nov 06, 10:16
Satellos Bioscience Shareholders Equity (Quarterly) : 59.91M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 59.91M |
| March 31, 2026 | 70.66M |
| December 31, 2025 | 27.78M |
| September 30, 2025 | 34.00M |
| June 30, 2025 | 38.35M |
| March 31, 2025 | 41.67M |
| December 31, 2024 | 47.19M |
| September 30, 2024 | 15.24M |
| June 30, 2024 | 21.31M |
| March 31, 2024 | 25.49M |
| December 31, 2023 | 30.85M |
| September 30, 2023 | 34.29M |
| June 30, 2023 | 37.17M |
| March 31, 2023 | 1.573M |
| December 31, 2022 | 2.486M |
| September 30, 2022 | 5.971M |
| June 30, 2022 | 5.436M |
| March 31, 2022 | 7.066M |
| December 31, 2021 | 8.298M |
| September 30, 2021 | 9.644M |
| June 30, 2021 | -0.1686M |
| March 31, 2021 | 0.2104M |
| December 31, 2020 | -0.1443M |
| September 30, 2020 | -0.3429M |
| June 30, 2020 | -0.1979M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0314M |
| December 31, 2019 | 0.5095M |
| September 30, 2019 | 1.028M |
| June 30, 2019 | -0.179M |
| March 31, 2019 | 0.1141M |
| December 31, 2018 | -0.4572M |
| September 30, 2018 | -0.2823M |
| June 30, 2018 | 0.0408M |
| March 31, 2018 | 0.5223M |
| December 31, 2017 | 0.8677M |
| September 30, 2017 | 1.039M |
| June 30, 2017 | 1.237M |
| March 31, 2017 | 1.452M |
| December 31, 2016 | 1.725M |
| September 30, 2016 | 1.934M |
| June 30, 2016 | 2.109M |
| March 31, 2016 | 2.262M |
| December 31, 2015 | 2.722M |
| September 30, 2015 | 3.296M |
| June 30, 2015 | 3.672M |
| March 31, 2015 | 4.203M |
| December 31, 2014 | 4.753M |
| September 30, 2014 | 5.692M |
| June 30, 2014 | 5.602M |
| March 31, 2014 | 8.127M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Xenon Pharmaceuticals, Inc. | 1.242B |
| Psyence Biomedical Ltd. | 11.87M |
| Aurinia Pharmaceuticals, Inc. | 657.52M |
| enGene Therapeutics, Inc. | 230.29M |
| Medicus Pharma Ltd. | -1.243M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 65.77M |
| Total Liabilities (Quarterly) | 5.861M |
| Current Ratio | 11.22 |